Elucidating the antidepressant actions of substance P (NK1 receptor) antagonists

Current Opinion in Investigational Drugs

Volumn 3, Issue 2, 2002, Pages 257-261

  Rupniak, Nadia M J ^a  

^a NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

Author keywords

Anxiety; Depression; NK1 receptor

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; APREPITANT; AUTORECEPTOR; FLUOXETINE; MONOAMINE; NEUROKININ 1 RECEPTOR; NEUROLEPTIC AGENT; NORADRENALIN; PAROXETINE; PLACEBO; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN UPTAKE INHIBITOR; SUBSTANCE P; SUBSTANCE P ANTAGONIST; TRICYCLIC ANTIDEPRESSANT AGENT;

ANXIETY; CLINICAL TRIAL; DEPRESSION; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; DRUG STRUCTURE; GASTROINTESTINAL SYMPTOM; GENE DELETION; HIPPOCAMPUS; HUMAN; NAUSEA; NERVE PROJECTION; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SEXUAL DYSFUNCTION; SIDE EFFECT; STRUCTURE ANALYSIS; SWEATING;

ANIMALS; ANTIDEPRESSIVE AGENTS; CLINICAL TRIALS; DEPRESSIVE DISORDER; DRUG EVALUATION, PRECLINICAL; HUMANS; MORPHOLINES; RECEPTORS, NEUROKININ-1; STRESS; SUBSTANCE P; TREATMENT OUTCOME;

EID: 0036230310     PISSN: 14724472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Distinct mechanism for antidepressant activity by blockade of central substance P receptors
2. Can the placebo be the cure?
3. Substance P antagonists: Novel agents in the treatment of depression
4. Update on Substance P (NK-1 receptor) antagonists in clinical trials for depression
5. Validity of clinical trials of antidepressants
6. 1) receptor antagonist (SPA) in major depression
7. Elevation of substance P-like peptides in the CSF of psychiatric patients
8. Dynorphin A and substance P in the cerebrospinal fluid of schizophrenic patients
9. CSF substance P immunoreactivity in affective disorders
10. 1) receptors in the cingulate cortex in unipolar and bipolar mood disorder and schizophrenia
11. Neurokinin-1 receptors are decreased in orbitofrontal cortex (ORB) in major depressive disorder (MDD)
12. Differential response of substance P-containing subtypes of adrenomedullary cells to different stressors
13. Stimulation of ACTH/cortisol by intravenously infused substance P in normal men: Inhibition by sodium valproate
14. Studies in psychoneuroimmunology: Psychological, immunological, and neuroendocrinological parameters in Israeli civilians during and after a period of Scud missile attacks
15. Beta-endorphin, but not substance-P, is increased by acute stress in humans
16. Elevation of serum substance P levels in major depression
17. Substance P: Correlation of CSF and plasma levels
18. 3H]SP as the radioligand
19. 1 receptor) antagonists
20. Animal models of depression: Empirical observations
21. 1 receptor internalisation in the basolateral amygdala
22. 1 receptor) antagonist L-760735 inhibits neonatal vocalisation in guinea-pigs
23. Evidence that substance P is utilized in the medial amygdaloid facilitation of defensive rage behavior in the cat
24. Substance P is involved in the sensitization of the acoustic startle response by foot shock in rats
25. Adult brain neurogenesis and psychiatry: A novel theory of depression
26. The chronic psychosocial stress paradigm in male tree shrews: Evaluation of a novel animal model for depressive disorders
27. Stress-induced changes in cerebral metabolites, hippocampal volume and cell proliferation are prevented by antidepressant treatment with tianeptine
28. 1) receptor antagonist and clomipramine prevent stress-induced alterations in cerebral metabolites, cytogenesis in the dentate gyrus and hippocampal volume
29. Serotonin and substance P co-exist in dorsal raphe neurons of the human brain
30. 1 receptors facilitates the activity of adrenergic pathways projecting to frontal cortex and dorsal hippocampus in rats
31. 1) receptor antagonists enhance dorsal raphe neuronal activity
32. Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic function
33. 1) receptor knock-out mice mimic antidepressant-induced desensitization
34. Stress-induced C-fos expression in the rat locus coeruleus is dependent on neurokinin 1 receptor activation
35. 1) receptor antagonist treatment increases burst firing of monoamine neurons in the locus coeruleus